Equity

MALHX

Large Cap Growth Fund

Overview

Loading

Performance

Performance

  • Returns



The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor’s shares, when sold or redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the performance quoted.

Growth of Hypothetical $10,000 The growth of hypothetical $10,000 chart reflects a hypothetical $10,000 investment and assumes reinvestment of dividends and capital gains. Fund expenses, including management fees and other expenses were deducted.

Performance chart data not available for display.
View full chart

Distributions

Interactive chart displaying fund performance. Javascript is required.

View full chart

Key Facts

Key Facts

Size of Class (Millions) as of 09-Dec-2016 $394.1 M
Size of Fund (Millions) as of 09-Dec-2016 $1,147.3 M
Share Class launch date 22-Dec-1999
Asset Class Equity
Morningstar Category Large Growth
Lipper Classification Large-Cap Core Funds
Benchmark Index Russell 1000 Growth Index
CUSIP 09250J874
Net, Excluding Investment Related Expenses 0.84%
Gross Expense Ratio 0.93%
Number of Holdings as of 30-Nov-2016 68
Max Offer Price as of 09-Dec-2016 $15.01
Open to New Investors Yes
Turnover Percent as of 30-Nov-2016 32%

Ratings

Ratings

Lipper Leader

 
Overall Lipper Leaders ratings based on an equal-weighted average of percentile ranks for each measure over 3-, 5-, and 10-year periods (if applicable) and do not take into account the effects of sales charges for these categories (Consistent Return, Preservation, Total Return, Expense, and Tax Efficiency) as of 30-Nov-2016 out of 780, 11,770, 782, 363 and 782 Funds, respectively in Lipper's Large-Cap Core Funds classification.

Holdings

Holdings

as of 30-Nov-2016
Name Weight (%)
APPLE INC 7.00
ALPHABET INC 6.02
MICROSOFT CORPORATION 5.25
COMCAST CORPORATION 3.83
HOME DEPOT INC 3.36
Name Weight (%)
ALTRIA GROUP INC 3.14
BIOGEN INC 2.63
AMGEN INC 2.61
UNITEDHEALTH GROUP INC 2.50
GILEAD SCIENCES INC 2.43

Exposure Breakdowns

Exposure Breakdowns

as of 30-Nov-2016

% of Market Value

Type Fund Benchmark Net
as of 30-Nov-2016

% of Market Value

as of 30-Nov-2016

% of Market Value

as of 30-Nov-2016

% of Market Value

Type Fund Benchmark Net
Negative weightings may result from specific circumstances (including timing differences between trade and settle dates of securities purchased by the funds) and/or the use of certain financial instruments, including derivatives, which may be used to gain or reduce market exposure and/or risk management.

Allocations are subject to change.

Portfolio Managers

Portfolio Managers

Peter Stournaras
Peter Stournaras
Portfolio Manager

Literature

Literature

 

More Products

How to Buy BlackRock Funds

How to Buy BlackRock Funds

There are many ways to access BlackRock Funds, learn how you can add them to your portfolio